Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Psychiatry (Edgmont (Pa. : Township))
|
September 1, 2010
Use of Antipsychotics Pre- and Post-Dissemination of CATIE Data
Elisa F Cascade, Amir H Kalali, Jeffrey Lieberman, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 3, 2006
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia
Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, et al.
The International Journal of Neuropsychopharmacology
|
April 4, 2001
Effects of risperidone on auditory event-related potentials in schizophrenia
Daniel Umbricht, Daniel Javitt, Gerald Novak, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 24, 2010
Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride
Mark Slifstein, Raymond F Suckow, Jonathan A Javitch, et al.
Schizophrenia Research
|
February 12, 2008
Association of RGS2 and RGS5 variants with schizophrenia symptom severity
Daniel B Campbell, Leslie A Lange, Tara Skelly, et al.
Schizophrenia Research
|
November 11, 2008
Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial
Robert A Rosenheck, Sonia Davis, Nancy Covell, et al.
Schizophrenia Research
|
October 22, 2008
A systematic method for estimating individual responses to treatment with antipsychotics in CATIE
Edwin J C G van den Oord, Daniel E Adkins, Joseph McClay, et al.
Schizophrenia Research
|
June 24, 2009
Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial
Robert A Rosenheck, Vicki G Davis, Sonia M Davis, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 31, 2015
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, et al.
International Journal of Psychiatry in Clinical Practice
|
May 13, 2017
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Psychiatry (Edgmont (Pa. : Township))
|
September 1, 2010
Use of Antipsychotics Pre- and Post-Dissemination of CATIE Data
Elisa F Cascade, Amir H Kalali, Jeffrey Lieberman, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 3, 2006
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia
Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, et al.
The International Journal of Neuropsychopharmacology
|
April 4, 2001
Effects of risperidone on auditory event-related potentials in schizophrenia
Daniel Umbricht, Daniel Javitt, Gerald Novak, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 24, 2010
Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride
Mark Slifstein, Raymond F Suckow, Jonathan A Javitch, et al.
Schizophrenia Research
|
February 12, 2008
Association of RGS2 and RGS5 variants with schizophrenia symptom severity
Daniel B Campbell, Leslie A Lange, Tara Skelly, et al.
Schizophrenia Research
|
November 11, 2008
Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial
Robert A Rosenheck, Sonia Davis, Nancy Covell, et al.
Schizophrenia Research
|
October 22, 2008
A systematic method for estimating individual responses to treatment with antipsychotics in CATIE
Edwin J C G van den Oord, Daniel E Adkins, Joseph McClay, et al.
Schizophrenia Research
|
June 24, 2009
Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial
Robert A Rosenheck, Vicki G Davis, Sonia M Davis, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 31, 2015
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, et al.
International Journal of Psychiatry in Clinical Practice
|
May 13, 2017
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, et al.
Page
of 7